Biomarker testing and treatment patterns in US patients (pts) with advanced/metastatic non‑small cell lung cancer (NSCLC) harboring MET amplification

2023

Ryder A, Oksen D, Boutmy E, Wang Y, Nisbett AR, Stroh C, Johne A